NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT00313599 2014-07-02Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsUniversity of California, San FranciscoPhase 1 Completed28 enrolled
NCT00667641 2011-05-10Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsRutgers, The State University of New JerseyPhase 1 Completed16 enrolled